You are here: All Products  > InxMed Adds $15 Million B+ Funding for China/US Pivotal Trials of FAK Inhibitor

InxMed Adds $15 Million B+ Funding for China/US Pivotal Trials of FAK Inhibitor

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products